SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 25.22-5.0%Dec 12 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: aknahow who wrote (6715)7/18/1998 8:11:00 AM
From: Robert K.  Read Replies (1) of 17367
 
>Bob, they got all existing, 7 U.S. and everything in the pipeline that may turn into a patent.
.......correct, but what about the european incy patent?

> Some think you did not know about the Incyte patents until they were called to your attention by some other posters on another board. How wrong they are!
........correct, as you know I thought they might be in discussions and didnt want to unintentionally screw matters up via our discussions.

> The only question was, would XOMA be able to remove this pebble from its path in an acceptable manner.
........correct, I have been looking for this event for years
IMO xomas position got stronger and stronger and brought incy to the table

You always thought they would do exactly what has occurred.
........correct, IMO it was necessary to clean things up prior to get-go

.......IMO most important is patent issues are GONE
......AND no more competition anywhere,anyplace that I can see
.....ONLY remaining issue is efficacy IMO(refer to Elsbach)

>Would you say that BPI/LBP could be considered a royal flush?
........?.. More like in blackjack, no other players in the game, we have 21 and the house needs 21 to beat us.

All imo all disclaimer apply.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext